We are monitoring the impact of COVID-19 on Europe CRO Services Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 6964
Share on
Share on

European Contract Research Organization Services Market Research Report - Segmented By Type, End-User, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Size, Share, Growth & Trends Forecast (2020 to 2025)

Pulished: February, 2020
ID: 6964
Pages: 145

Europe CRO Services Market Size (2020 to 2025)

The size of the European Contract Research Organization Services Market is estimated to grow USD 10.70 billion by 2025 from USD 7.95 billion in 2020, at a CAGR of 6.12% from 2020 to 2025.

Clinical research, consultation, and laboratory CRO services are progressively utilized by pharmaceutical industries, which is the primary factor accelerating the European region's CRO services market. Expenses for research and development regarding the procedure of discovering, testing, and upgrading new products accelerate market growth. In Germany, the pharmaceutical industries' expenses in 2018 are likely to have increased from USD7,100.6 million in 2015 to USD 7,113.2 million, according to data published by the European Federation of Pharmaceutical Industries and Associations (EFPIA). The enormous patient count is one factor in surging the market. Growing awareness in healthcare, escalating demand for therapeutically successful products, and upgrading technologies are likely to drive the Europe CRO services market.

Factors like snowballing administrative stress on contract research organization, problems in detecting personnel with proficiency for particular projects, and the absence of highly experienced professionals are likely to restrain the CRO services market growth in Europe. Also, strict regulations for the approval of drugs may impede the market.

This research report on the European CRO services market has been segmented & sub-segmented into the following categories:

By Type:

  • Clinical Research Services                
  • Phase I Clinical Research Services              
  • Phase II Clinical Research Services             
  • Phase III Clinical Research Services           
  • Phase IV Clinical Research Services           
  • Early-Phase Development Services                              
  • Discovery Studies             
  • Chemistry, Manufacturing, & Control (CMC)        
  • Preclinical Services           
    • Pharmacokinetics/Pharmacodynamics (PK/PD)
    • Toxicology Testing Services
    • Other Preclinical Services
  • Laboratory Services                             
  • Bioanalytical Testing Services      
  • Analytical Testing Services            
    • Physical Characterization
    • Raw Material Testing
    • Batch-Release Testing
    • Stability Testing
    • Other Analytical Testing Services
  • Consulting Services                

By Therapeutic Area:

  • Oncology
  • CNS
  • Cardiovascular    

By End-User:

  • Pharmaceutical
  • Biopharmaceutical
  • Medical Device Companies

By Country:

  • United Kingdom
  • Spain
  • Germany
  • Italy
  • France
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Rest of Europe

Regionally, Europe has the second-largest share in the market. It can be attributed to the high-quality pharmaceutical industry standards, rapid growth in the biosimilars and biologics market, the surge in demand for outsourcing services by pharmaceutical and biopharmaceutical companies, and the rise in the number of clinical trials in this region.

UK is on top of leading the CRO services market in Europe. Vital significance towards research and development activities by the region’s superior pharmaceutical, biotechnology, and Medtech enterprises fuel this region's growth. Europe is dominating the CRO equipment growth because of an increase in non-communicable diseases like diabetes, cardiovascular diseases, cancer, and chronic diseases. Europe region accounts for a rise in non-communicable diseases, with nearly 77% of the disease stress and anxiety, which immediately enlarges CROs' stipulation to stop the frequency of the diseases.

Germany followed after the UK in driving the market growth due to the survival of top income-producing pharmaceutical companies investing a considerable amount in R & D to impel the country's market growth.

Promising companies leading the Europe Contract Research Organization (CRO) Services Market profiled in this report are Quintiles Transnational Holdings Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, PAREXEL International Corporation, ICON Plc, PRA Health Sciences Inc., InVentiv Health Inc., Charles River Laboratories International Inc., INC Research Holdings Inc., and Wuxi PharmaTech.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                          

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                    

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Type                                              

                                5.1.1 Introduction                           

                                5.1.2 Clinical Research Services                 

                                                5.1.2.1 Phase I Clinical Research Services              

                                                5.1.2.2 Phase II Clinical Research Services             

                                                5.1.2.3 Phase III Clinical Research Services           

                                                5.1.2.4 Phase IV Clinical Research Services           

                                5.1.3 Early-Phase Development Services                              

                                                5.1.3.1 Discovery Studies             

                                                5.1.3.2 Chemistry, Manufacturing, & Control (CMC)        

                                                5.1.3.3 Preclinical Services           

                                                                5.1.3.3.1 Pharmacokinetics/Pharmacodynamics (PK/PD)

                                                                5.1.3.3.2 Toxicology Testing Services

                                                                5.1.3.3.3 Other Preclinical Services

                                5.1.4 Laboratory Services                             

                                                5.1.4.1 Bioanalytical Testing Services      

                                                5.1.4.2 Analytical Testing Services            

                                                                5.1.4.2.1 Physical Characterization

                                                                5.1.4.2.2 Raw Material Testing

                                                                5.1.4.2.3 Batch-Release Testing

                                                                5.1.4.2.4 Stability Testing

                                                                5.1.4.2.5 Other Analytical Testing Services

                                5.1.5 Consulting Services                             

                                5.1.6 Y-o-Y Growth Analysis, By Product                               

                                5.1.7  Market Attractiveness Analysis, By Product                            

                                5.1.8  Market Share Analysis, By Product                              

                5.2 Therapeutic Area                                     

                                5.2.1 Introduction                           

                                5.2.2 Oncology                 

                                5.2.3 CNS                            

                                5.2.4 Cardiovascular                       

                                5.2.5 Y-o-Y Growth Analysis, By Therapeutic Area                            

                                5.2.6 Market Attractiveness Analysis, By Therapeutic Area                          

                                5.2.7 Market Share Analysis, By Therapeutic Area                            

                5.3 End User                                      

                                5.3.1 Introduction                           

                                5.3.2 Pharmaceutical                     

                                5.3.3 Biopharmaceutical                               

                                5.3.4 Medical Device Companiest                            

                                5.3.5 Y-o-Y Growth Analysis, By End User                             

                                5.3.6  Market Attractiveness Analysis, By End User                          

                                5.3.7  Market Share Analysis, By End User                            

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Therapeutic Area        

                                                6.1.3.3 By Type 

                                                6.1.3.4 By End User        

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Therapeutic Area        

                                                6.1.4.3 By End User        

                                                6.1.4.4 By Application    

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Therapeutic Area        

                                                6.1.5.3 By Type 

                                                6.1.5.4 By End User        

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                              

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Quintiles Transnational Holdings Inc.                                               

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Laboratory Corporation of America Holdings                                               

                8.3 Pharmaceutical Product Development                                           

                8.4 PAREXEL International Corporation                                  

                8.5 ICON Plc                                       

                8.6 PRA Health Sciences Inc.                                       

                8.7 InVentiv Health Inc.                                

                8.8 Charles River Laboratories International Inc.                                

                8.9 INC Research Holdings Inc.                                  

                8.10 Wuxi PharmaTech.                                

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                                         

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                                          

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of Composite type, by End User along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

                                                                                                                          

  1. Europe Contract Research Organization Services Market, By Type, From 2020 to 2025 (USD Billion)
  2. Europe Preclinical Market, By Region, From 2020 to 2025 (USD Billion)
  3. Europe Clinical Research Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Laboratory Market, By Region, From 2020 to 2025 (USD Billion)
  5. Europe Contract Research Organization Services Market, By Therapeutic Area, From 2020 to 2025 (USD Billion)
  6. Europe Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe CNS Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe Cardiovascular Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Contract Research Organization Services Market, By End User, From 2020 to 2025 (USD Billion)
  10. Europe Pharmaceutical Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Biopharmaceutical Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Medical Device Companie Market, By Region, From 2020 to 2025 (USD Billion)
  13. U.K. Contract Research Organization Services Market, By Type, From 2020 to 2025 (USD Billion)
  14. U.K. Contract Research Organization Services Market, By Therapeutic Area, From 2020 to 2025 (USD Billion)
  15. U.K. Contract Research Organization Services Market, By End User, From 2020 to 2025 (USD Billion)
  16. Germany Contract Research Organization Services Market, By Type, From 2020 to 2025 (USD Billion)
  17. Germany Contract Research Organization Services Market, By Therapeutic Area, From 2020 to 2025 (USD Billion)
  18. Germany Contract Research Organization Services Market, By End User, From 2020 to 2025 (USD Billion)
  19. France Contract Research Organization Services Market, By Type, From 2020 to 2025 (USD Billion)
  20. France Contract Research Organization Services Market, By Therapeutic Area, From 2020 to 2025 (USD Billion)
  21. France Contract Research Organization Services Market, By End User, From 2020 to 2025 (USD Billion)
  22. Italy Contract Research Organization Services Market, By Type, From 2020 to 2025 (USD Billion)
  23. Italy Contract Research Organization Services Market, By Therapeutic Area, From 2020 to 2025 (USD Billion)
  24. Italy Contract Research Organization Services Market, By End User, From 2020 to 2025 (USD Billion)
  25. Spain Contract Research Organization Services Market, By Type, From 2020 to 2025 (USD Billion)
  26. Spain Contract Research Organization Services Market, By Therapeutic Area, From 2020 to 2025 (USD Billion)
  27. Spain Contract Research Organization Services Market, By End User, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample